Bora CDMO Bora CDMO

X

Find Radio Compass News for Cilofexor

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-and-yuhan-corp-in-us870m-nash-deal.html

EUROPEAN BIOTECHNOLOGY
02 Jul 2019

https://www.reuters.com/article/us-gilead-sciences-insitro-nash/gilead-teams-up-with-insitro-for-experimental-nash-treatments-idUSKCN1RS11J?feedType=RSS&feedName=healthNews

Saumya S. Joseph REUTERS
17 Apr 2019

http://www.pharmatimes.com/news/gilead_announces_novo_nordisk_nash_partnership_after_new_data_revealed_1284382

Anna Smith PHARMA TIMES
15 Apr 2019

https://www.reuters.com/article/us-novo-nordisk-gilead-sciences-nash/novo-nordisk-and-gilead-team-up-to-test-fatty-liver-disease-treatment-idUSKCN1RO0Y3?feedType=RSS&feedName=healthNews

Stine Jacobsen REUTERS
13 Apr 2019

https://www.fiercebiotech.com/biotech/gilead-posts-combo-nash-data-from-biotech-buyouts

Ben Adams FIERCE BIOTECH
11 Apr 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY